Massimo Moro

5PUBLICATIONS
96CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 10, 2026
The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers.

|Sep 18, 2023
A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumors.

Maria Eugénia Marques Da Costa, Sakina Zaidi, Jean-Yves Scoazec

|Sep 17, 2022
Establishment of 6 pediatric rhabdomyosarcoma patient's derived xenograft models closely recapitulating patients' tumor characteristics.

Patrizia Gasparini, Michela Casanova, Giovanni Centonze

|Mar 01, 2018
Author Correction: Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness.

Massimo Moro, Giulia Bertolini, Roberto Caserini

|Jul 29, 2017
Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness.

Massimo Moro, Giulia Bertolini, Roberto Caserini

Pageof 1

Frequent Collaborators

2 joint publications

Patrizia Gasparini

2 joint publications

Maria Eugénia Marques Da Costa

2 joint publications

Sakina Zaidi

2 joint publications

Gudrun Schleiermacher